CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.91 +0.00 (+0.00%)
As of: Oct 22, 2026 · 3:59 PM EDT

CytoMed Therapeutics (GDTC) Operating Expenses (2022 - 2026)

Updated

CytoMed Therapeutics (GDTC) posted Operating Expenses of $398,866 for Q2 2026, compared with $34,734 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Operating Expenses (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at CytoMed Therapeutics was $1.28 million; for FY2025, it was $1.7 million.

  • In prior years, CytoMed Therapeutics' Operating Expenses was -$2.02 million in FY2024, -$1.69 million in FY2023, -$2.45 million in FY2022 and -$1.98 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Operating Expenses since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 11.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 10.56 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 9.70 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 18.20 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 6.68 Bn
10 CytoMed Therapeutics 10.46 Mn 855,548.76 - 398,866.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 398,866.00
Jun 30, 2025 368,049.00
Jun 30, 2024 360,204.00
Jun 30, 2023 958,077.00
Jun 30, 2022 732,375.00
API Access

CytoMed Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=GDTC&period=max&api_key=YOUR_API_KEY